• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec16
Pharmaceutical Industry M&A Value Up 31% in 2025 to $179.6 Billion
17:43
Nov24
Avidity Biosciences Inc. Special Shareholder Meeting to Vote on Novartis Merger Agreement
22:11
Nov19
Avidity Biosciences Announces Management Access Program for DMD Patients
14:14
Nov14
FactSet analysts lower 2025 EPS forecast for Avidity Biosciences Inc
12:22
Nov11
RBC Capital analyst reiterates hold rating on Avidity Biosciences
12:32
Avidity Biosciences released FY2025 9 Months Earnings on November 10 (EST), with actual revenue of USD 17.9 M and EPS of USD -3.3836
04:00

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.48 M, Net Income -174.44 M, EPS -1.265

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.847 M, Net Income -157.32 M, EPS -1.2136

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.573 M, Net Income -115.77 M, EPS -0.9

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More